Alpha Centric Advisors LLC Galapagos Nv Transaction History
Alpha Centric Advisors LLC
- $118 Million
- Q3 2024
A detailed history of Alpha Centric Advisors LLC transactions in Galapagos Nv stock. As of the latest transaction made, Alpha Centric Advisors LLC holds 108,500 shares of GLPG stock, worth $2.9 Million. This represents 2.64% of its overall portfolio holdings.
Number of Shares
108,500
Previous 108,500
-0.0%
Holding current value
$2.9 Million
Previous $2.69 Million
16.18%
% of portfolio
2.64%
Previous 2.22%
Shares
11 transactions
Others Institutions Holding GLPG
# of Institutions
85Shares Held
12.3MCall Options Held
69.1KPut Options Held
42.7K-
Bvf Inc San Francisco, CA1.57MShares$42 Million1.44% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY1.41MShares$37.8 Million0.76% of portfolio
-
Prosight Management, LP Dallas, TX1.03MShares$27.5 Million7.95% of portfolio
-
Logos Global Management LP San Francisco, CA800KShares$21.4 Million3.05% of portfolio
-
Primecap Management CO Pasadena, CA720KShares$19.3 Million0.02% of portfolio
About GALAPAGOS NV
- Ticker GLPG
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,835,500
- Market Cap $1.76B
- Description
- Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...